Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This study is looking at how sepsis—a serious infection that affects the whole body—can impact the heart, specifically causing a condition called myocarditis, which is inflammation of the heart muscle. Researchers at Jimma University Medical Center in Ethiopia want to understand how often heart problems happen in adults with sepsis, how these problems affect recovery, and whether they last over time. They will follow patients for one year to see how their heart health and overall survival change after having sepsis.
Adults aged 18 and older who are diagnosed with sepsis and admitted to the medical center can join the study, as long as they don’t already have known heart disease before getting sepsis and are willing to be part of the study for a full year. Participants will have their heart health checked using symptoms, blood tests, heart rhythm tests (ECG), and ultrasound pictures of the heart (echocardiography). The study will help doctors learn which heart problems during sepsis might lead to worse outcomes, aiming to improve care and support for patients with sepsis-related heart issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All adult patients aged 18 years and above diagnosed with sepsis admitted to Jimma University Medical Center during the study periods that are willing to participate and continue follow-up of their disease condition for at least one year.
- Exclusion Criteria:
- • Patients with any kind of pre-existing established cardiac disease prior to their sepsis diagnosis and those who are not willing to participate or not willing to have follow-up of their disease condition for at least one year.
About Jimma University
Jimma University is a leading academic institution in Ethiopia, renowned for its commitment to advancing health sciences and promoting research initiatives. As a clinical trial sponsor, Jimma University leverages its extensive expertise in public health and medicine to conduct rigorous and ethical research aimed at addressing critical health challenges in the region. The university collaborates with various stakeholders, including local and international research organizations, to enhance the quality and impact of its clinical studies. By fostering innovation and knowledge dissemination, Jimma University plays a pivotal role in improving health outcomes and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jimma, Oromia, Ethiopia
Patients applied
Trial Officials
Nikolaus Alexander Haas, MD, Pediatician, Cardiologist
Study Chair
Ludwig Maximillians University of Munich, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported